Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:21 PM
Ignite Modification Date:
2025-12-24 @ 10:21 PM
NCT ID:
NCT05947435
Eligibility Criteria:
Inclusion Criteria:
* 18-70 years old
* ASA I-III patients
* scheduled for PCNL surgery
Exclusion Criteria:
* tranexamic acid hypersensitivity
* history of subarachnoid haemorrhage
* previous cerebrovascular event
* a history of arterial-venous embolism or a tendency to thromboembolism
* abnormal liver function tests
* unstable cardiovascular disease
* acute or chronic renal failure
* the presence of any haematological disease and known colour blindness
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT05947435
Study Brief:
Protocol Section:
NCT05947435